Lucid Diagnostics Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$2.0M
Doctors Paid
4,775
Transactions
8,989
2024 Total
$393,957
Payment Breakdown by Category
Research$1.3M (64.2%)
Consulting$462,154 (22.5%)
Food & Beverage$241,355 (11.8%)
Travel$22,730 (1.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1.3M | 180 | 64.2% |
| Consulting Fee | $462,154 | 167 | 22.5% |
| Food and Beverage | $241,355 | 8,594 | 11.8% |
| Travel and Lodging | $22,730 | 21 | 1.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $7,790 | 27 | 0.4% |
Payments by Type
Research
$1.3M
180 transactions
General
$734,028
8,809 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| A Multicenter Case-Control Study of the Efficacy of EsoGuardO on Samples Collected Using EsoCheckO, versus Esophagogastroduodenoscopy, for the Diagnosis of Barretts Esophagus with and without Dysplasia, and for Esophageal Adenocarcinoma | $411,603 | 0 | 39 |
| Clinical Utility Study of EsoGurad on Samples Collected using EsoCheck as a Triage for Endoscopy to Identify Barretts Esophagus | $299,970 | 0 | 16 |
| Analysis andCell sampleCollection- aRetrospective analysis of the clinicalUtility of theEsoCheck device andEsoGuard analysis | $221,226 | 0 | 3 |
| BE2 | $170,917 | 0 | 18 |
| Identifying Individuals at Risk for Barretts Esophagus in a Large Health System Using a Validated Screening Model | $100,000 | 0 | 2 |
| A Multicenter, Single-Arm Study of the Efficacy of EsoGuard on Samples Collected Using EsoCheck versus Esophagogastroduodenoscopy for the Diagnosis of Barretts Esophagus in an At-Risk Screening Population | $60,810 | 0 | 18 |
| Clinical Utility of a Non endoscopic Device EsoCheck and Biomarker EsoGuard as Alternative to Endoscopy for Screening for Barretts Esophagus in At Risk Population (ASBE) A Randomized Controlled, Virtual Patient Trial | $31,500 | 63 | 63 |
| BE1 | $10,205 | 0 | 2 |
| Clinical Utility of a Non endoscopic Device EsoCheck and Biomarker EsoGuard as Alternative to Endoscopy for Screening for Barretts Esophagus in At Risk Population (ASBE) A Randomized Controlled | $9,500 | 19 | 19 |
Payments by Medical Specialty
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2023 |
|---|---|---|---|---|
| Dr. David Poppers, Md, Phd, MD, PHD | Gastroenterology | New York, NY | $108,114 | $0 |
| Alfred Lui, M.d, M.D | Anatomic Pathology | Torrance, CA | $72,797 | $0 |
| Dr. Nicholas Shaheen, Md, MD | Gastroenterology | Chapel Hill, NC | $66,143 | $0 |
| Sanford Markowitz, Md, MD | Hematology & Oncology | Cleveland, OH | $51,655 | $0 |
| Dr. Seper Dezfoli, M.d, M.D | Gastroenterology | Beverly Hills, CA | $37,854 | $0 |
| Amitabh Chak, Md, MD | Gastroenterology | Cleveland, OH | $27,437 | $0 |
| Dr. Jess Savala, M.d, M.D | Anatomic Pathology & Clinical Pathology | Los Angeles, CA | $22,502 | $0 |
| Joseph Willis, Md, MD | Anatomic Pathology | Cleveland, OH | $20,625 | $0 |
| Dr. Daniel Tseng, M.d, M.D | Surgery | Portland, OR | $11,837 | $0 |
| Badi Eghterafi, D.o, D.O | Family Medicine | Henderson, NV | $11,621 | $0 |
| Dr. Richard Gomez, Md, MD | Anatomic Pathology & Clinical Pathology | Dallas, TX | $9,186 | $0 |
| Dr. Jordan Roberts, M.d, M.D | Family Medicine | Holladay, UT | $8,298 | $0 |
| Dr. Danny Lister, Md, MD | Surgery | Heber Springs, AR | $7,607 | $0 |
| Dr. Christopher Ducoin, Md, Mph, MD, MPH | Surgery | Tampa, FL | $7,068 | $0 |
| Arvind Trindade, Md, MD | Gastroenterology | New Brunswick, NJ | $6,936 | $0 |
| Dr. Philip Woodworth, Md, MD | Surgery | Lone Tree, CO | $6,626 | $0 |
| Dr. Sachin Wani, Md, MD | Gastroenterology | Aurora, CO | $5,000 | $0 |
| Dr. Rhonda Souza, Md, MD | Gastroenterology | Dallas, TX | $3,250 | $0 |
| Dr. Stuart Spechler, M.d, M.D | Gastroenterology | Dallas, TX | $3,027 | $0 |
| Evan Dellon, M.d., M.p.h, M.D., M.P.H | Gastroenterology | Chapel Hill, NC | $2,750 | $0 |
| Shail Maheshwari, Md, MD | Gastroenterology | Shenandoah, TX | $2,496 | $0 |
| Jayde Kurland, Md, MD | Internal Medicine | Lima, OH | $1,855 | $0 |
| Mallu Reddy, Md, MD | Internal Medicine | Pomona, CA | $1,595 | $0 |
| Dr. Christine Berg, M.d, M.D | Specialist | Bethesda, MD | $1,500 | $0 |
| Sheena Patel, M.d, M.D | Gastroenterology | Lima, OH | $1,248 | $0 |
Ad
Top Products
- ESOCHECK CCD CELL COLLECTION DEVICE $91,584
Associated Products (1)
Payment Categories
- Food & Beverage $241,355
- Consulting $462,154
- Travel & Lodging $22,730
- Research $1.3M
About Lucid Diagnostics Inc.
Lucid Diagnostics Inc. has made $2.0M in payments to 4,775 healthcare providers, recorded across 8,989 transactions in the CMS Open Payments database. In 2024, the company paid $393,957. The top product by payment volume is ESOCHECK CCD CELL COLLECTION DEVICE ($91,584).
Payments were distributed across 118 medical specialties. The top specialty by payment amount is Gastroenterology ($292,987 to 432 doctors).
Payment categories include: Food & Beverage ($241,355), Consulting ($462,154), Research ($1.3M), Travel & Lodging ($22,730).
Lucid Diagnostics Inc. is associated with 1 products in the CMS Open Payments database.